Atea Pharmaceuticals, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -22.51%39.44%
EBIT Margin -22.68%39.38%
EBITDA Margin -22.51%34.49%
Operating Margin -22.68%39.38%
Net Margin -22.51%34.49%
FCF Margin 610.10%-24.76%
Efficiency
Assets Average 818.26M
Equity Average 628.94M
Invested Capital 547.80M710.08M
Asset Utilization Ratio 0.43
Leverage & Solvency
Equity Ratio 0.630.92
Valuation
Enterprise Value 2,601.62M-21.44M400.61M254.48M282.95M
Market Capitalization 3,451.74M742.94M400.61M254.48M282.95M
Return Ratios
Return on Sales -0.23%0.34%
Return on Capital Employed 0.18%
Return on Invested Capital 0.19%
Return on Assets 0.15%
Return on Equity 0.19%